Tomato Good Carrier For Alzheimer’s Vaccine - Korea Study
This article was originally published in PharmAsia News
South Korean scientists say they have found that injecting tomatoes with a vaccine to prevent Alzheimer's disease is an effective preventative. Experiments using mice showed that when the gene of a beta-amyloid protein was injected into the genome of a tomato, it led to an effective immune response in the animals. The Korea Research Institute of Bioscience and Biotechnology researchers said the tomato proved to be a suitable carrier for the vaccine. The beta-amyloid is believed to be the cause of Alzheimer's. (Click here for more
You may also be interested in...
Drug companies involved in Alzheimer's disease research are a little fed up with FDA. Some, like Wyeth, believe the agency should put Alzheimer's research higher up on its priority list and allow the use of surrogate endpoints for clinical trials. But FDA says that no validated surrogate exists for Alzheimer's, and until it has hard data from products in development, it is loath to recommend one. A recent reorganization of the agency's neurology group may provide an opening to press home those arguments.
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.